주메뉴 바로가기 본문 바로가기

아산 주요뉴스 모아보기

  • 2026년 서울아산병원 임상약리학과 임상강사 추가모집 - 모집인원: 2명
    - 지원자격: 임상약리 전공의 수료자 or 타과 전문의 자격 소지자
    - 접수기간: 별도 문의 (sec@acp.kr / 02-3010-4622)
    자세히보기

닫기

Journal Review

Journal Review 상세페이지
PK-RNN-V E A deep learning model approach to vancomycin therapeutic drug monitoring using electronic health record data
첨부파일 : PK-RNN-V E A deep learning model approach to vancomycin therapeutic drug monitoring using electronic health record data_20251224.pdf

논문명: PK-RNN-V E: A deep learning model approach to vancomycin therapeutic drug monitoring using electronic health record data

 

Abstract

Vancomycin is a commonly used antimicrobial in hospitals, and therapeutic drug monitoring (TDM) is required to optimize its efficacy and avoid toxicities. Bayesian models are currently recommended to predict the antibiotic levels. These models, however, although using carefully designed lab observations, were often developed in limited patient populations. The increasing availability of electronic health record (EHR) data offers an opportunity to develop TDM models for real-world patient populations. Here, we present a deep learning-based pharmacokinetic prediction model for vancomycin (PK-RNN-V E) using a large EHR dataset of 5,483 patients with 55,336 vancomycin administrations. PK-RNN-V E takes the patient's real-time sparse and irregular observations and offers dynamic predictions. Our results show that RNN-PK-V E offers a root mean squared error (RMSE) of 5.39 and outperforms the traditional Bayesian model (VTDM model) with an RMSE of 6.29. We believe that PK-RNN-V E can provide a pharmacokinetic model for vancomycin and other antimicrobials that require TDM.

 

발표일자: 2025.12.24

 

발표자: 이효은 선생님

 

  • 현재 페이지를 인쇄하기
페이지 처음으로 이동
05505 서울특별시 송파구 올림픽로 43길 88 서울아산병원
TEL 1688-7575 webmaster@amc.seoul.kr
Copyright@2014 by Asan Medical Center. All Rights reserved.
  • 바로가기
  • 바로가기
  • 바로가기
  • 바로가기
  • 서울아산병원, 20년 연속 존경받는 병원 1위
  • 서울아산병원, 美 뉴스위크 평가 세계 22위·국내 1위
  • 서울아산병원, 정보보호 관리체계 ISMS 인증 획득